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Purpose: Inflammation has been implicated as a contributing factor in the expansion of 
abdominal aortic aneurysms (AAA). To test this hypothesis, we examined the effects of a 
monoclonal antibody (MAB) to the leukocyte CD18 adhesion molecule on the expansion 
of experimental AAA. 
Methods: Aneurysms were induced by perfusion of an isolated segment of the infrarenal 
aorta with elastase in 22 normotensive (WKY) and 17 genetically hypertensive (WKHT) 
rats. Animals of both strains were randomly allocated to control or MAB-treated groups 
(MAB, 5 ~g/100 gm body weight intraperitoneally, daily, beginning on the operative day 
for a total of four doses). The activity of the MAB against rat leukocytes had first been 
determined by in vitro immunofluorescence flow cytometry. Aortic size was directly 
measttred initially and on day 14. At that time, a segment of aorta was stained with 
hematoxylin and eosin and mononuclear leukocytes and neutrophils were counted in each 
of 10 microscopic fields (400 x ). 
Results: The initial aortic size in all animals was 1.11 + 0.15 mm. All groups developed 
aneurysms ignificantly larger than the initial aortic size (p < 0.01). However, the 
MAB-treated animals had significantly smaller aneurysms than the tmtreated controls 
(mm): WKY: 3.63 + 1.26, WKY-MAB: 2.08 --- 0.30, WKHT: 4.54 + 1.86, WKHT- 
MAB: 2.37 - 0.40, p < 0.0001. There also were significantly fewer monocytes in the 
MAB-treated normotensive rats: WKY: 35.5 + 29.9, WKHT: 40.6 + 28.8, WKY-MAB: 
8.9 + 8.5, WKHT-MAB: 32.3 + 25.7, p = 0.03. Neutrophil counts did not differ 
significantly between the groups. 
Conclusions: Treatment with anti-CD18 monoclonal ntibody slows the expansion of AAA 
in this experimental model. The associated inflammatory process at day 14, as indicated 
by monocyte infiltration, is reduced, but this effect may be opposed by the presence of 
hypertension. Further evaluation of the role of leukocytes and adhesion molecules in the 
expansion of AAA is warranted. (J VAsc SURG 1996;23:301-7.) 
Although the initial event leading to abdominal 
aortic aneurysm (AAA) formation remains amystery, 
it seems clear that increased elastase activity and 
degradation of elastic fibers in the aortic wall is 
followed by progressive enlargement. Although pre- 
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vious experimental work has shown that hyperten- 
sion accelerates AAA expansion, 2 3 evidence is accu- 
mnlating that the inflammation plays a significant 
role in the development of AAA. 3-1~ Inflammation 
within the media and adventitia of the aortic wall 
appears as a consistent component of aortic aneu- 
rysms. Rizzo et al. 4 demonstrated histologically that 
inflammatory cells are prominent in the adventitia 
and present in the media of most aneurysms, with 
little or none seen in control aortas taken at autopsy 
from patients without aneurysms. Koch and cowork- 
ers ~ compared the aortas of patients with aneurysms 
to those with occlusive disease and found increased 
inflammatory cells in the media and adventitia, 
increased amounts of macrophages, and increased 
numbers of lymphocytes in the aneurysmal aortas. 
Using a rat aneurysm odel experimentally, Anidjar 
and colleagues 7 demonstrated a temporal correlation 
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between the development of the inflammatory infil- 
trate and the progressive enlargement of AAA. 
To investigate the role of inflammation and 
hypertension on the expansion of experimental 
AAA, we hypothesized that inhibition of leukocyte 
adhesion would slow the growth of elastase-induced 
AAA in normotensive and hypertensive rats. Ad- 
ditionally, we hypothesized that AAA in the hy- 
pertensive rats would grow more than those in 
normotensive rats, even after inhibition of leukocyte 
adhesion, because it was expected that high blood 
pressure and inflammation would act independently 
on AAA expansion. 
MATERIAL AND METHODS 
In vitro testing ofmonoclonal ntibody. Whole 
blood isolates were obtained from a normal human 
volunteer and a Wistar-Kyoto (WKY) rat. Leuko- 
cytes were isolated by centrifuging heparinized blood 
at 1500 rpm with Histopaque (Sigma Chemical Co., 
St. Louis) for 30 minutes. Plasma was removed and 
residual red blood cells were lysed with a water and 
3.6% saline solution. The lenkocytes were washed 
and one million cells were suspended in i ml of 
Dulbecco's phosphate-buffered saline (PBS; without 
calcium and magnesium, Life Technologies, Grand 
Island, NY). 
The CD18 monoclonal antibodies (MAB) used 
were similar to the TA-4 clone to the rat MAC-1 
(CDllb/CD18) and LFA-1 (CDlla/CD18) be- 
longing to the [32-integrin group (#278004-1, Seika- 
gaku America, Rockville, Md.). This MAB has been 
shown to be effective in blocldng leukocyte aggrega- 
tion, endothelial cell adhesion, and in vivo lympho- 
cyte infiltration.14 For this portion of the experiment, 
the dose and reactivity of the TA-4 clone was 
determined by immunofluorescent flow cytometry. 
Twenty micrograms of TA-4 was added to a test tube 
of either rat or human leukocyte isolates. Sixty 
micrograms of the monoclonal anti-CD18 antibody 
60.3 (Bristol-Myers Squibb Pharmaceutical Research 
Institute, Seattle, Wash.), a mouse antihuman leu- 
kocyte antibody, was added to additional test ubes of 
rat and human leulmcyte isolates. The cells were 
incubated for 30 minutes on ice, fixed with 0.5% 
paraformaldehyde for 5 minutes, washed twice with 
5% heat-inactivated f tal calf serum, suspended in25 
txl offluorescein-detecting goat anti-mouse antibody, 
and incubated for 30 minutes on ice. They were 
washed with 5 % fetal calf serum then with 1% bovine 
serum albumin in PBS, and then resuspended in
0.5% paraformaldehyde. 15 Immunofluorescent flow 
cytometry was performed the day of isolation and 
labeling using a fluorescence-activated c ll sorter 
(Epich Elite, Coulter Electronics, Miami, Fla.). 
Both human and rat cells were incubated with: 
(1) 60.3 and goat anti-mouse antibody, (2) goat 
anti-mouse antibody, and (3) TA-4 and goat anti- 
mouse antibody. 
Flow cytometry confirmed TA-4 (CD18 MAB) 
binding to rat leukocytes and 60.3 to human 
leukocytes. With the TA-4, complete saturation of 
one million leukocytes (granulocytes and monocytes) 
was achieved with 20 >g (1:500 dilution). There are 
approximately 1.4 × 107 leukocytes in a milliliter of 
rat blood and approximately 6 ml of blood in a 
100-gm rat (4.5-6.5 ml/100 gin), or 8.4 × 107 
leukocytes per 100-gm rat. At the 1:500 dilution, 
there were 4.0 × 10 -1° gm MAB. The original test 
sample had 1.0 × 106 cells, so 3.4 × 106 gm MAB 
were needed to saturate the cells. Because absorption 
from intraperitoneal injection of MAB can be ex- 
pected to be 80% of the administered dose, 16 the final 
dose administered in these xperiments was increased 
to 5 t,g/100 gm body weight (BW) to compensate 
for the intraperitoneal pharmacokinetics. 
Animal model. Animals were housed at the 
University of Vermont and cared for according to the 
Guide for the Care and Use of Laboratory Animals 
(NIH Publication #86-23, revised 1985). The hy- 
pertensive animals were bred at the University of 
Vermont) 2Two strains of rats (5.5 _+ 2.3 months) 
were used: normotensive Wistar-Kyoto rats and 
genetically hypertensive Wistar-Kyoto (WKHT) 
rats) 2 Rats weighed 217.8 + 22.5 gm (range, 169- 
280 gin). Hypertensive animals had tail plethysmog- 
raptly weekly 2,12a3 and were not used in the experi- 
ment until sustained systolic hypertension was re- 
corded. In more than 13 years of working with these 
rats, spontaneous development of aortic aneurysms 
has not been observed. 
AAA were induced in rats as previously de- 
scribed. 2,13 Briefly, anesthesia was induced with 
intraperitoneal chloral hydrate (300 mg/kg), the 
abdomen was opened in the midline, and with the aid 
of a binocular surgical microscope (9 × ), the infra- 
renal aorta was exposed and its diameter measured 
with a micrometer. Arterial branches from the level of 
the renal arteries to bifurcation were clamped. A 
polyethylene catheter (PE10) was inserted via the left 
iliac artery and advanced until the tip was within the 
aorta. Intraarterial blood pressure was measured. The 
catheter was secured temporarily with a ligature just 
above the aortic bifurcation and the aorta was 
occluded below the renal vessels with a clamp, 
producing an isolated 1-cm segment of aorta. The 
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isolated segment of aorta was infused with an elastase 
solution (15 units of porcine pancreatic elastase; 
Type I, E-1250, Sigma Chemical Co,, in 2 ml PBS, 
pH 8.6-8.8) for 2 hours. The residual elastase then 
was aspirated from the aorta, the catheter was 
removed, and the iliac vessel igated. After surgery, 
the rats received four doses of buprenorphine (0.01 
mg/kg subcutaneously every 12 hours). 
After 14 days, the animals were reanesthetized 
with chloral hydrate and under physiologic ondi- 
tions the aorta was measured again. The animals were 
then killed by exsanguination. The aneurysmal orta 
was carefully dissected free of adherent tissue, rinsed, 
stored in formalin, and submitted for routine hema- 
toxylin and eosin and Leder's stain. Mononuclear 
cells and neutrophils were counted in each specimen 
per 10 high-powered fields (400 × ) by an experi- 
enced histopathologist (RG). 
Experimental design. Before surgery, animals of 
both strains were allocated randomly to control or 
treatment groups. Animals in the treatment groups 
received 5 txg of the CD18 MAB per 100 gm of body 
weight intraperitoneally beginning on the operative 
day (before the start of anesthesia). The infusion was 
continued aily for 3 days (total, four doses). Thus 
four groups were studied (Table I). 
Statistics. All data are expressed as the mean _+ 
standard eviation. Analysis between groups was by 
the one-way analysis of variance (ANOVA) with 
Bonferroni's adjustment to confirm points of sig- 
nificance and the Student's t test. A p value of 0.05 
or less was considered significant. All statistical 
calculations were done on an IBM-compatible com- 
puter using In Star 2.05 (Graph Pad Software, San 
Diego, Calif.). 
RESULTS 
The initial aortic size in all animals was 
1.11 _+ 0.15 mm. Mean intraarterial blood pres- 
sure (under anesthesia) was significantly higher in 
the WKHT animals: WKY: 94.2 ± 12.8, WKHT: 
116.6 + 36.6 (p < 0.0001), as seen previously. 2,13 
Aneurysms developed in all animals that were 
significantly larger than the initial aortic size 
(p < 0.01). Aneurysms were significantly smaller in 
both groups treated with MAB (Figure 1). 
Control animals in both groups displayed a loss of 
the normal architecture of the aortic wall with flank 
necrosis in some cases. There was disruption of any 
remaining elastin fibers. Treated rats, conversely, 
showed preservation of the normal architecture with 
preservation of the elastin layers. Patchy inflamma- 
tory infiltrate was observed in the control animals, 
Table 1. Study groups 
Group No. of subjects 
Control 
I WKY 11 
II WKHT 9 
Treatment 
III WKY-MAB 1 I 
IV WICHT-MAB 8 
and this was markedly reduced in the MAB-treated 
groups. 
Neutrophil and monocyte counts are shown in 
Table II. Representative specimens are shown in 
Figure 2. There was no significant difference in 
neutrophil counts at day 14. WKY-MAB rats had 
significantly fewer monocytes than WKY rats, but 
there was no difference between control and MAB- 
treated WKHT rats. There was also no difference 
between WKY and WKHT rats. 
DISCUSSION 
Using the elastase-gencrated model of AAA in 
rats, Anidjar and coworkcrs 7 correlated the expansion 
of AAA with inflammatory infiltration. Two and one 
half days after infusion with elastase, thc aortas 
dilated 300%, from 1.04 -+ 0.02 mm to 3.09 - 
0.08 mm (p < 0.05). Immunohistologic studies 
showed macr0phages and T cells in the media. By day 
6, the aorta was 421% larger (4.38 +_ 0.03 mm, 
p < 0.05) and the numbers ofmacrophages, neutro- 
phils, and T lymphocytes wcrc increased further. 
Additionally, in a second set of experiments, a
nonspecific activator of the immune system (thiogly- 
colatc plus plasmin) was infused instead of clastin. 
The aorta again enlarged with the infiltration of 
macrophages but more slowly. In the first set of 
experiments the aortas were devoid of stainable 
elastin and rapidly enlarged, with a "secondary" 
enlargement that coincided with the maximal inflam- 
matory infiltration. The second set of experiments 
saw principally a macrophage infiltration with de- 
layed but steady expansion. 
This cellular infiltration also was sccn and furthcr 
characterized by Halpern et al~0 using this elastase- 
perfusion model. They examined the aortas at 1, 2, 3, 
and 6 days after infusion. Neutrophils, ED-2 positive 
macrophages, and CD4-positive T-helper cells had 
early increases (23 days) in the aneurysmal aortas 
(leading to our choice of MAB treatment up to day 
4). In addition, IgM was detected on the external 
elastic lamina, suggesting that the cellular infiltration 
may be a specific immune response to disrupted 
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Fig. 1. Final aortic aneurysm size (mm) in all four groups at 14 days. ANOVA, p < 0.0001. 
* WKY versus WKY-MAB, p < 0.001, ** WKHT versus WKHT-MAB, p < 0.001. 
Table II. White blood cell counts 
Neutrophils Monocytes 
WKY 19.4 _+ 21.6 35.5 _+ 29.9 
WKHT 16.3 _+ 21.6 40.6 _+ 28.8 
WKY-MAB 7.2 _+ 13.1 8.9 -+ 8.5 
WKHT-MAB 36.3 _+ 33.3 32.3 _+ 25.7 
A_NOVA p = 0.12 p = 0.032* 
Average counts per 10 high-power fields. 
*WKY vs. WKY-MAB, p = 0.0125; WKHT vs. WKHT-MAB, p = 0.40. 
elements within the aorta rather than a nonspecific 
response to injury. In both of these studies, the 
infiltration of  inflammatory cells coincided with the 
enlargement of the aorta, leading these authors to 
suggest this infiltration was responsible for aortic wall 
destruction and the formation of  AAA. 7,1° 
In the present experiments we simply turned the 
question around, asking whether inhibition of in- 
flammatory cells would prevent AAA enlargement. 
Dobrin had demonstrated previously that inhibition 
of the inflammatory response with steroids and 
cyclosporin reduced aneurysm size. 16 Because Anid- 
jar et al7 demonstrated the involvement of lympho- 
cytes, macrophages, and neutrophils, the CD18 
MAB was chosen to affect the widest possible 
inhibition of leukocytes. The [3-subunit CD18 is 
noncovalently inked to three ~-subunits, CD l la ,  
CD 11 b, or CD 1 l c. The CD 11/CD 18 heterodimer is 
expressed on all leukocytes)  The CDl l /CD18 
heterodimer complexes with intracellnlar adhesion 
molecules, and adhesion is primarily the result of 
conformational changes. Antibodies bind close to 
adhesive sites and prevent adhesion by steric hin- 
drance) 9 It is likely that both unstimulated and 
stimulated neutrophils are inhibited by the CD18 
MAB, whereas unstimulated monocytes are only 
partially inhibited by the MAB to CDlS. Stimulated 
monocytes, however, display increased inhibition by 
the MAB. 18 The CD18 MAB has been demonstrated 
to decrease leukocyte-endothelial cell adhesion. It 
also prevents neutrophil emigration i  vitro as well as 
in a variety of experimental disease states. 14,18'19 
Inhibition of leukocyte adhesion diminishes the 
inflammatory esponse by preventing further steps in 
the response. 19 
As hypothesized, administration of the CD18 
MAB reduced the magnitude of aortic dilation, 
corresponding tothe "primary" dilation from the loss 
of elastin reported by Anidjar et al.7 The monocyte 
response was significantly decreased in normotensive 
animals at 14 days, and neutrophils showed a 
nonsignificant trend in this direction as well. It is 
possible that earlier inhibition ofneutrophil adhesion 
prevented the progressive steps in the inflammatory 
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Fig. 2. Histologic results of representative tissue specimen (hematoxylin and eosi  stain, 
400 × ). A, Control WKY rat aorta with a marked inflammatory infiltrate, primarily composed 
of lymphocytes but including polymorphonuclear leukocytes and plasma cells. The normal 
architecture ofthe aortic wall isdisrupted, manifested by the disorder of the smooth muscle cells 
and elastic fiber bundles. B, Aortic wall from a CD18 MAB-treated WKY rat shows orderly, 
concentric layers of mooth muscle cells and layers of elastic fibers. Inflammatory cell infiltration 
is absent. C, Aortic wall from this WKHT control rat shows a marked inflammatory esponse 
consisting of polymorphonuclear leukocytes and mononuclear cells. The luminal aspect of the 
wall demonstrates intimal hyperplasia as well as disruption and loss of internal elastic lamina. 
D, Aorta from a MAB-treated WKHT rat shows orderly arrangement of smooth muscle cells, 
a prominent internal elastic lamina, andno appreciable inflammatory infiltrate. 
response, including monocyte infiltration, as sug- 
gested above. TM This is presently being investigated. 
Additionally, because it has previously been 
demonstrated that hypertension significantly in- 
creases aneurysm expansion, 2a3 we hypothesized that 
hypertension would act independently from the 
inflammatory response to increase aortic size. This 
was not confirmed. This would suggest that although 
hemodynamic forces exert a force on the expansion of 
AAA, these forces are secondary to the dilation seen 
in association with the inflammatory cell infiltration. 
We have observed variation in the size of the AAA 
in our various studies, 2,13 particularly with the 
WKHT strain. Although this is likely due to slight, 
unidentified variations in technique, it speaks to the 
importance of concurrent controls with this model. 
A corresponding significant decrease in the num- 
ber of monocytes at 14 days was not seen in 
hypertensive animals, an observation that is unex- 
plained. It is known that elastin fragments are 
chemotactic for monocytes but offer less of a stimulus 
for neutrophils, 2° whereas collagen fragments are 
chemotactic for monocytes only. 21 It is possible that 
unidentified stimuli n the hypertensive rats (such as 
collagen fragmentation in the hypertensive aorta) led 
to monocyte chemotaxis, but that the early phase of 
neutrophil infiltration was blocked, preventing the 
"secondary" enlargement discussed above. Another 
explanation may relate to the reported finding that 
WKHT rats have greater numbers of circulating 
lymphocytes.22 
Evidence of the role of the inflammatory esponse 
in human AAA is also accumulating. Brophy and 
co-workers 6 found a mononuclear infiltrate in 8 of 10 
aortic aneurysms similar to that seen in this experi- 
mental study. They also found significant deposition 
of immunoglobullns (later seen in their experimental 
study as welll°). Workers at Northwestern University 
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used human AAA samples to investigate he signifi- 
cance of the inflammatory infiltration seen within the 
media and adventitia of aneurysmal ortas. 4,~ Few 
inflammatory cells were present in the normal aorta 
and only a mild infiltration was seen in atherosclerotic 
aortas, s Degenerative aortic aneurysms, however, 
had much greater inflammatory infiltration. The 
predominant cell type in the AAA tissue was the 
CD3-positive T lymphocytes (66%), which were 
found primarily in the adventitia, ggregating around 
the vasa vasorum. Additionally, ahigh proportion of 
CD4-positive T-helper cells was found in the aneu- 
rysmal aorta, compared with normal aortas and 
peripheral blood. CD19-positive lymphocytes, rare 
in the occlusive aorta, constituted about 25% of the 
infiltrate in AAA tissue, primarily in the adventitia. 
Frequently these lymphocytes were surrounded by 
clusters of CD3-positive cells. Macrophages tended 
to parallel the general inflammatory esponse, and 
were distributed in the media and adventitia with 
equal frequency. These authors postulated that the 
CD3 T-cells, particularly the CD4 subset, might be 
responsible for the release of interlenkin-2, which 
activates and causes the proliferation of CD-3 posi- 
tive T cells and CD19-positive B cells. These B cells, 
with macrophages and smooth muscle cells, can 
process antigen and perpetuate he immune response. 
Macrophages can release interleukin-l[3 (IL-I[3), 
which is chemotactic for CD3-positive and CD19- 
positive lymphocytes. They also can release tumor 
necrosis factor alpha (TNF-c~), which can influence 
the endothelial cell layer and affect lipolytic activity, 
perhaps playing a role in AAA development. 
Subsequent work from this group has suggested 
that such cytokine activity (particularly IL-113) by 
macrophages and lymphocytes i responsible for 
regulating the increase in matrix protein turnover 
present in AAA. 11 Moreover, Newman and co- 
workers 8 have demonstrated increased TNF-a and 
IL- l[3in AAA tissue compared with control athero- 
sclerotic aortas. These investigators also found that 
tissue metalloproteinases (MMP), a diverse group of 
substances responsible for extracellular matrix de- 
struction, are increased inAAA, 24 and that he MMPs 
found in AAA tissue are localized to mononuclear 
cells (MMP-9) and macrophages (MAVIP-3, u-PA) .  9 
Considerable evidence xists to support an active 
role for the inflammatory esponse in the expansion 
of AAA, rather than merely that of an epi- 
phenomenon that accompanies AAA. By inhibiting 
the cellular components of the inflammatory re- 
sponse, this study, which is the first to demonstrate 
that AAA expansion can be limited with MAB 
treatment, adds weight o this hypothesis. Although 
the inciting event remains amystery, 8 it would seem 
that the elastase-generated AAA model, which mim- 
ics human aneurysms histologically, 2,23 also repro- 
duces the early events of aneurysm formation, 
especially the inflammatory response seen in hu- 
mans. 4,7,10 Thus it is a superior model for the study of 
AAA, particularly the secondary effects of inflamma- 
tion on extracellular matrix destruction. 
The authors thank Lori Shatney and Beverly Batty for 
their assistance with these xperiments. 
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